AAG
GILD icon

Accordant Advisory Group’s Gilead Sciences GILD Stock Holding History

Accordant Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$111K Hold
875
– – 0.07% 65
2026
Q1 		$122K Buy
875
+525
+150% +$73.5K 0.08% 56
2025
Q4 		$43K Buy
+350
New +$42.5K 0.03% 85
2024
Q3 		– Sell
-200
Closed -$13.7K – 152
2024
Q2 		$13.7K Buy
+200
New +$13.3K 0.01% 115

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Accordant Advisory Group's GILD Position: Q2 2026 in Review

Accordant Advisory Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 875 shares worth $111K. The position accounts for 0.07% of the portfolio, ranked #65.

Accordant Advisory Group first reported a position in GILD in Q2 2024 and has held it in 4 quarters since. The position peaked at $122K in Q1 2026. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Accordant Advisory Group held 875 shares of Gilead Sciences worth $111K as of Q2 2026.
  • Accordant Advisory Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.07% of Accordant Advisory Group's portfolio in Q2 2026, its #65 holding.
  • Accordant Advisory Group first reported a position in Gilead Sciences in Q2 2024 and has held it in 4 quarters since.
  • Accordant Advisory Group's Gilead Sciences position peaked at $122K in Q1 2026.
  • 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Accordant Advisory Group's 13F filing for Q2 2026, filed 27 Jul 2026.